News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Bridge Pharmaceuticals, Inc. Takes On China With $22M Series B
May 30, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
5/30/2006 - Bridge Pharmaceuticals Inc., a contract drug researcher looking to perform studies in greater China for biotech and pharmaceutical companies, has raised $22 million in Series B financing.
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
Series B
Kailera Banks Massive $600M Raise for Phase III Obesity Study
October 14, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
Violations at Novo’s Indiana Plant ‘Unacceptable,’ FDA Says
October 14, 2025
·
2 min read
·
Tristan Manalac
Artificial intelligence
Takeda Makes $1B+ AI Bet With Nabla to Build Out Early Pipeline
October 14, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Novo Retreats From Cell Therapy, Axes Hundreds as Restructuring Rolls On
October 13, 2025
·
2 min read
·
Tristan Manalac